These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 11100038)
1. Transplacental passage of maternal pemphigus foliaceus autoantibodies induces neonatal pemphigus. Avalos-Díaz E; Olague-Marchan M; López-Swiderski A; Herrera-Esparza R; Díaz LA J Am Acad Dermatol; 2000 Dec; 43(6):1130-4. PubMed ID: 11100038 [TBL] [Abstract][Full Text] [Related]
2. Pregnant women with endemic pemphigus foliaceus (Fogo Selvagem) give birth to disease-free babies. Rocha-Alvarez R; Friedman H; Campbell IT; Souza-Aguiar L; Martins-Castro R; Diaz LA J Invest Dermatol; 1992 Jul; 99(1):78-82. PubMed ID: 1607681 [TBL] [Abstract][Full Text] [Related]
3. Pemphigus vulgaris in a neonate and his mother. Kodagali SS; Subbarao SD; Hiremagaloor R Indian Pediatr; 2014 Apr; 51(4):316-7. PubMed ID: 24825277 [TBL] [Abstract][Full Text] [Related]
4. Neonatal pemphigus in an infant born to a mother with serologic evidence of both pemphigus vulgaris and gestational pemphigoid. Panko J; Florell SR; Hadley J; Zone J; Leiferman K; Vanderhooft S J Am Acad Dermatol; 2009 Jun; 60(6):1057-62. PubMed ID: 19467379 [TBL] [Abstract][Full Text] [Related]
5. Neonatal pemphigus vulgaris with extensive mucocutaneous lesions from a mother with oral pemphigus vulgaris. Campo-Voegeli A; Muñiz F; Mascaró JM; García F; Casals M; Arimany JL; Amagai M; Camps A Br J Dermatol; 2002 Oct; 147(4):801-5. PubMed ID: 12366435 [TBL] [Abstract][Full Text] [Related]
6. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. Amagai M; Hashimoto T; Green KJ; Shimizu N; Nishikawa T J Invest Dermatol; 1995 Jun; 104(6):895-901. PubMed ID: 7539469 [TBL] [Abstract][Full Text] [Related]
7. The plant lectin wheat germ agglutinin inhibits the binding of pemphigus foliaceus autoantibodies to desmoglein 1 in a majority of patients and prevents pathomechanisms of pemphigus foliaceus in vitro and in vivo. Ortiz-Urda S; Elbe-Bürger A; Smolle J; Marquart Y; Chudnovsky Y; Ridky TW; Bernstein P; Wolff K; Rappersberger K J Immunol; 2003 Dec; 171(11):6244-50. PubMed ID: 14634141 [TBL] [Abstract][Full Text] [Related]
8. [Pemphigus diseases in children and adolescents]. Meurer M Hautarzt; 2009 Mar; 60(3):208-16. PubMed ID: 19242669 [TBL] [Abstract][Full Text] [Related]
9. The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic. Ding X; Diaz LA; Fairley JA; Giudice GJ; Liu Z J Invest Dermatol; 1999 May; 112(5):739-43. PubMed ID: 10233765 [TBL] [Abstract][Full Text] [Related]
10. Neonatal pemphigus foliaceus. Hirsch R; Anderson J; Weinberg JM; Burnstein P; Echt A; Fermin J; Heilman ER; Laude TA J Am Acad Dermatol; 2003 Aug; 49(2 Suppl Case Reports):S187-9. PubMed ID: 12894119 [TBL] [Abstract][Full Text] [Related]
11. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453 [TBL] [Abstract][Full Text] [Related]
12. A subset of pemphigus foliaceus patients exhibits pathogenic autoantibodies against both desmoglein-1 and desmoglein-3. Arteaga LA; Prisayanh PS; Warren SJ; Liu Z; Diaz LA; Lin MS; J Invest Dermatol; 2002 May; 118(5):806-11. PubMed ID: 11982757 [TBL] [Abstract][Full Text] [Related]
13. Pathogenicity and epitope characteristics of anti-desmoglein-1 from pemphigus foliaceus patients expressing only IgG1 autoantibodies. Hacker-Foegen MK; Janson M; Amagai M; Fairley JA; Lin MS J Invest Dermatol; 2003 Dec; 121(6):1373-8. PubMed ID: 14675185 [TBL] [Abstract][Full Text] [Related]
14. Anti-Desmoglein 1 and 3 Autoantibody Levels in Endemic Pemphigus Foliaceus and Pemphigus Vulgaris from Brazil. Oliveira LA; Marquart-Filho A; Trevilato G; Timoteo RP; Mukai M; Roselino AM; Petzl-Erler ML Clin Lab; 2016 Jul; 62(7):1209-1216. PubMed ID: 28164651 [TBL] [Abstract][Full Text] [Related]
15. Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies. Hacker MK; Janson M; Fairley JA; Lin MS Clin Immunol; 2002 Oct; 105(1):64-74. PubMed ID: 12483995 [TBL] [Abstract][Full Text] [Related]
16. Influence of IVIg therapy on autoantibody titers to desmoglein 1 in patients with pemphigus foliaceus. Sami N; Bhol KC; Ahmed AR Clin Immunol; 2002 Nov; 105(2):192-8. PubMed ID: 12482393 [TBL] [Abstract][Full Text] [Related]
17. Pemphigus foliaceus antigen: characterization of an immunoreactive tryptic fragment from BALB/c mouse epidermis recognized by all patients' sera and major autoantibody subclasses. Labib RS; Rock B; Martins CR; Diaz LA Clin Immunol Immunopathol; 1990 Nov; 57(2):317-29. PubMed ID: 2208810 [TBL] [Abstract][Full Text] [Related]
18. Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus. España A; Koga H; Suárez-Fernández R; Ohata C; Ishii N; Irarrazaval I; Teye K; Ohyama B; Hashimoto T Eur J Dermatol; 2014; 24(2):174-9. PubMed ID: 24776707 [TBL] [Abstract][Full Text] [Related]
19. Non-pathogenic pemphigus foliaceus (PF) IgG acts synergistically with a directly pathogenic PF IgG to increase blistering by p38MAPK-dependent desmoglein 1 clustering. Yoshida K; Ishii K; Shimizu A; Yokouchi M; Amagai M; Shiraishi K; Shirakata Y; Stanley JR; Ishiko A J Dermatol Sci; 2017 Mar; 85(3):197-207. PubMed ID: 28024684 [TBL] [Abstract][Full Text] [Related]
20. Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus. Futei Y; Amagai M; Ishii K; Kuroda-Kinoshita K; Ohya K; Nishikawa T J Dermatol Sci; 2001 May; 26(1):55-61. PubMed ID: 11323221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]